The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Rosuvastatin 10 mg Film-coated Tablets

Centrient Pharmaceuticals Netherlands B.V.PA22813/001/002

Main Information

Trade NameRosuvastatin 10 mg Film-coated Tablets
Active SubstancesRosuvastatin
Dosage FormFilm-coated tablet
Licence HolderCentrient Pharmaceuticals Netherlands B.V.
Licence NumberPA22813/001/002

Group Information

ATC CodeC10AA HMG CoA reductase inhibitors
C10AA07 rosuvastatin


License statusWithdrawn
Withdrawn Date19/12/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0006-002-003
Interchangeable List DocumentPDF of Interchangeable List
« Back